Table 1.
Baseline Clinical and Demographic Characteristics of the total sample, the sertraline and nortriptyline conditions, and the four patients groups classified by treatment condition and responder status (complete case data).
| Variable | Total Sample (n=63) |
Sertraline (n= 33) |
Nortriptyline (n= 30) |
Sertraline Responders (n=11) |
Sertraline Non-responders (n=22) |
Nortriptyline Responders (n=16) |
Nortriptyline Non-responders (n=14) |
|---|---|---|---|---|---|---|---|
| Age | 64.19 (8.47) | 64.85 (8.83) | 63.47 (8.15) | 65.82 (9.19) | 64.36 (8.82) | 63.25 (8.94) | 63.71 (7.47) |
| Women (%) | 60 | 61 | 60 | 45 | 68 | 63 | 57 |
| Education, Yr | 16.17 (2.42) | 16.29 (2.14) | 16.04 (2.73) | 17.40 (.52) | 15.67 (2.45) | 16.23 (2.35) | 15.83 (3.19) |
| HRSD Baseline | 24.37 (4.87) | 23.91 (4.38) | 24.87 (5.39) | 23.18 (4.56) | 24.27 (4.36) | 24.81 (4.45) | 24.93 (6.47) |
| CGI-Severity Baseline | 4.35 (.93) | 4.38 (.71) | 4.33 (1.12) | 4.30 (.82) | 4.41 (.67) | 4.63 (.72) | 4.00 (1.41) |
| CIRS-G | 3.11 (2.14) | 3.52 (2.22) | 2.70 (2.0) | 3.30 (1.83) | 3.60 (2.48) | 2.25 (1.69) | 3.21 (2.26) |